Close Menu

Clinical Proteomics

News on proteomics applications for clinical use in genetics, genomics, and molecular diagnostics.

The antibody profiling will allow Oncimmune to identify which patients are more likely to respond to or experience adverse effects from immunotherapy.

BostonGene will analyze the tumors of patients enrolled in NEC or NEC-affiliated clinical trials and NEC will use the data to help improve treatment responses.  

The DoD and VA-led initiative is moving beyond its initial focus on lung cancer to add analyses of multiple cancer types and a prospective, multisite study.

Researchers affiliated with the Pancreatic Cancer Action Network found that treatment based on patient molecular profiles improved progression-free survival.